Sales in the cooperation business increased by 36% to EUR 12.6 million in the financial year (2023: EUR 9.3 million). The agreement concluded with Novartis in April 2024 for the two asthma products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback